![Martin Weiss Next AI Bonanza [Disruptors & Dominators Review]](https://e8u6c7p8.delivery.rocketcdn.me/wp-content/uploads/2023/10/Martin-Weiss-Next-AI-Bonanza.jpg)
Wondering if Martin Weiss Next AI Bonanza is the real deal? This detailed Disruptors & Dominators review will give you all the information you need to make an informed decision.
Martin Weiss just launched an urgent presentation on the next AI opportunity.
Already, this AI-powered industry is gaining powerful momentum. It’s 100x bigger than ChatGPT. And already, Martin Weiss’ stock ratings have helped deliver major profits for investors in the field of AI.
Take Nvidia, for example, the biggest AI chipmaker.
In 2023, after Wall Street finally discovered it, Nvidia shares rose 191%, truly a big win.
But Martin Weiss stock ratings identified Nvidia as a “Buy” way back in 2011, and investors who bought it then could have seen gains of 9,624%. That’s over 50 times better than what investors made if they just discovered Nvidia this year.
Plus, Nvidia is not the only big gain investors could have seen with Martin Weiss “Buy”-rated AI stocks.
Investors who recently bought another AI stock based on his “Buy” rating could have enjoyed gains of 810%. That was ASML. On Lam Research, they could have done even better: gains of 3,146%. And if folks bought Ansys when Martin Weiss first recommended it, they’d be up 5,466%.
Today, Martin Weiss and his team at Weiss Ratings are moving on to the next phase of the AI revolution, which, based on their data, could be 100 times bigger.
— RECOMMENDED —
The No. 1 AI Stock of 2023 (Not Nvidia)
It’s not Nvidia, Meta Platforms, Alphabet, or Amazon. But thanks to a recent major deal, an under-the-radar stock could become the No. 1 winner of the 2023 AI boom. “This company just teamed up with one of the biggest power players in the AI industry… yet you can still buy it for just one-twelfth the price of Nvidia – the time to buy is NOW,” says Marc Chaikin.
Click here for the name and ticker.
Martin Weiss Next AI Bonanza – What Is It?
According to Martin Weiss, the artificial intelligence is about to cause a multitrillion-dollar disruption in one of the most important industries known to man.
In fact, a recent article in Forbes says the new AI breakthroughs will not only save billions of lives …
They will also create the world’s first trillionaires.
Here, Martin Weiss is talking about healthcare, including pharmaceuticals, biotech and life sciences.
According to a just-released study by Goldman Sachs, healthcare is especially ripe for disruption by artificial intelligence. In fact, it was the first large industry to use artificial intelligence in a major way.
For years and years, it has used AI-based diagnostics in radiology, in pathology and in patient monitoring.
Healthcare was the first major sector in the world to use AI for one simple reason: It already had Big Data that AI needs.
It already had the precision instruments that could be programmed with AI.
It always had the urgent need: To help save lives! And fortunately, healthcare stocks are also where Martin Weiss stock ratings have beaten every other analyst and every other algorithm we know of.
Since they first issued “Buy” ratings on the nation’s most promising healthcare companies, investors could have used them to build very substantial wealth.
Even the worst performer on Martin Weiss early “Buy” list — Pfizer — is up 179%, or nearly triple your money.
In total, in the first three years of Martin Weiss stock ratings, they gave “Buy” ratings to 34 healthcare companies, which they’ve never since downgraded to a “Sell.”
On these 34 stocks they picked, investors could have seen average gains of 2,245%, or more than 23 times their money.
How was that possible? Martin Weiss brought together a dedicated team of experts to give you the opportunity to build real wealth from AI healthcare.
The leader of the team is Jon Markman.
— RECOMMENDED —
Must See: Incredible New Stock-Predicting AI System
The financial industry is the next in line to be completely disrupted by artificial intelligence. And leading that charge is a groundbreaking AI algorithm called An-E.
What makes An-E so revolutionary? There are two reasons: 1) An-E can predict stock prices four weeks in the future with incredible accuracy… and 2) It’s specifically designed for the everyday person – NOT Wall Street.
And you can begin using it today on 3,000 stocks.
Click here to see it in action
Who Is Jon Markman?
For two decades, Jon has been in the forefront of technology and investments.
For the past 10 years, not only has Jon worked extensively with Weiss data scientists and analysts to improve the formulas behind Weiss stock ratings …
He’s also a Microsoft veteran from the days Bill Gates ran the company.
That’s when Jon worked personally and directly with their software geniuses to create a computerized, algorithm-based stock picker, called StockScouter.
StockScouter became the heart of Microsoft’s money website, MSN Money, where Jon was the managing editor.
But that was just the prelude to Jon’s illustrious career at Weiss Ratings.
Soon after he joined Weiss Ratings 10 years ago, Jon became one of the first tech analysts in the world to predict four major tech megatrends: mobile computing, big data, autonomous vehicles, new medical technologies and, yes, artificial intelligence.
And today all four of those megatrends have become massive profit engines for investors.
In 2019, three years before AI burst onto the scene with ChatGPT, Jon clearly predicted this new phase of the AI boom.
It was at the Money Show in Las Vegas. Thousands of investors attended.
And Jon’s PowerPoint presentation, “Profiting from the AI Revolution”, not only predicted what’s happening now, but but it also pinpointed some of the biggest winners.
All thanks to his long years of experience and Weiss stock ratings.
And now, Jon Markman has just prepared three urgent reports to give investors everything they need to jump into this AI-driven healthcare boom.
Picks for the Best AI Healthcare Investments for 2023?
Jon’s first report is How to Profit from Revolutionary, AI-Assisted Drug Discoveries.
In his new report, How to Invest in Revolutionary AI-Assisted Drug Discoveries, Jon Markman not only maps out the future potential of using AI to discover new pharmaceuticals …
He also names the one company that can give investors the greatest, and safest, potential gains in this field.
This is the area that’s expected to grow at an annual rate of 39.9% over the next few years.
That’s a much higher growth rate than we’ve seen in the AI market as a whole.
Jon’s second special report is How to Ride the Boom in AI-Based Diagnostics.
– AI will be able to detect subtle signs and image configurations in CT scans that doctors would otherwise miss.
– It will be able to sift through blood samples with amazing speed and efficiency to find things that specialists could not find despite many years of training.
– AI-based personal apps will help millions of people diagnose or at least get a good head start on the diagnostic process for common or even uncommon diseases.
In this report, Jon shows you why he predicts that each of these AI technologies is about to spark separate booms in the companies that make or service them.
Jon Markman’s third special report is How to Ride the Explosion in AI Surgical Technology.
We talked about the surgical robot “da Vinci” which was launched more than 10 years ago and has performed more than 10 million surgeries in 67 countries.
Well, the name of the company that’s behind da Vinci is Intuitive Surgical.
So, it’s no coincidence it was on our “Buy” list right from the beginning.
And it’s up 6,256% since then.
Nor should you be surprised to hear that Jon has been recommending it for a long time.
At that same Money Show in Los Angeles, when Jon told thousands of investors about the coming revolution in AI, he also highlighted Intuitive Surgical.
Jon told them that Intuitive Surgical was a “tech quadruple play” and “a first mover in cutting-edge surgical tools.”
And now Jon says:
“If you think the 6,256% gains we’ve seen since our ‘Buy’ rating of Intuitive Surgical was a stroke of luck, wait till you see how much the shares of these kinds of companies could surge when they do just one thing: when they marry tried-and-tested surgical hardware with the newest AI software.”
In his report, Jon identifies the best of the best.
Right now, the stocks on Jon’s “urgent buy” list are relatively cheap.
The only way to get these reports and to learn their names and tickers is to try Jon’s monthly letter, Disruptors & Dominators.
Disruptors & Dominators – What Is It?
As the name implies, Disruptors & Dominators gives you both sides of the great innovations we see in the world today.
It covers the new, rapidly emerging technologies or companies that disrupt our world for the better.
And it covers the existing great technologies or well-established companies that already dominate their industry.
— RECOMMENDED —
Legendary Forecaster: “Weird A.I. powered ‘M.A.P.’ going berserk”
Go here and watch the first two minutes of this urgent briefing now.
Because this weird “A.I. powered M.A.P.” has helped legendary forecaster Jason Bodner nail some of the biggest calls of his career.
- Accurately predict every market top and bottom of the last decade (CORRECT)
- Identify the #1 stock of 2022 (CORRECT)
- Pinpoint over 20 triple-digit winners last year (CORRECT)
Jason’s M.A.P. system even pinpointed peak gains of 2,120%, 2,230%, and 5,900%.
But now this system is going berserk over something else entirely.
If you own any stocks (not just A.I. stocks)…
What’s Included with your Disruptors & Dominators Subscription?
Here’s everything that you’ll get:
With each issue you’ll get critical insights on both …
- The new, rapidly emerging technologies and companies that DISRUPT our world for the better. And …
- The existing great technologies or well-established companies that already DOMINATE their industry.
That’s what Martin Weiss considers the best of both worlds — the opportunity for faster, often explosive growth and the opportunity for safer, longer-term, sustainable growth.
Disruptors & Dominator Trade Alerts
In addition to giving you timely guidance on which stocks to buy, Weiss Ratings team also want to make sure you know which ones to sell and when. So …
You also get warnings about threats to your savings and retirement. They’ve warned readers about public companies, they also alert you to the best-of-the-best stocks based on their ratings.
- Use Weiss ratings on over 10,000 stocks, 3,000 ETFs and 25,000 mutual funds to decide which investments to buy, sell or hold — and when.
- Use Weiss ratings to zero in on the tech sector — to avoid the traps and find the truly best tech stock opportunities right now.
- If you wish, drill down still further to AI stocks or any tech sector that’s got solid momentum (not just hot today and cold tomorrow).
- Create an unlimited number of watch lists. As soon as there’s a downgrade or upgrade, you will get an alert via email, SMS or Telegram.
Weiss Ratings Daily alerts
Timely updates on all the above in your inbox every morning, seven days a week. (Also available via SMS and Telegram.)
How to Invest in Revolutionary AI-Assisted Drug Discoveries
How to Ride the Boom in AI-Based Diagnostics
How to Ride the Explosion in AI Surgical Technology
Disruptors & Dominators Subscription Fee
When you claim your membership today, you can get everything for just $78.
Disruptors & Dominators Refund Policy
Martin Weiss and his team are giving you a full year to review everything you get in your entire Disruptors & Dominators membership package …
You will have 365 days to dive into all the special reports you can download today … the 12 Disruptors & Dominators issues you’ll receive … the 53,000 Weiss ratings you can access 24/7 for the year … the 365 daily updates you receive … and much, much more.
If you’re not happy, for any reason, with your membership, simply contact Weiss Ratings Member Care Team, and you’ll receive a prompt refund of every penny.
Disruptors & Dominators Review – Final Words
Healthcare is where AI is now beginning to change people’s lives in a truly fundamental way.
It’s where select companies are already making major advances.
And it’s where Martin Weiss is convinced investors have the best AI opportunity of all.
Think about it for a moment. How much money have you spent on AI lately? Maybe a few bucks on ChatGPT, right? Or maybe nothing at all.
Even if you spent hundreds of dollars on AI, it’s chump change compared to the thousands — tens of thousands of dollars that are spent on medicines, surgeries and preventative care for just one person every year.
In fact, for the average retired American today, the lifetime cost for healthcare is $1,016,891.
This helps explain why the revenues in the healthcare industry are about 100 times larger than all the revenues we’ve seen in generative AI so far.
But based on Martin Weiss research, healthcare is not just a larger opportunity. It’s also a safer opportunity.
So, sure, it was great to ride the first phase of the AI boom, investing in companies like …
- Lam Research, up 3,146% since Martin Weiss told investors to buy …
- Ansys, up 5,466% since Martin told investors to buy …
- And Nvidia up 9,624% since Martin Weiss told investors to buy.
But now, Martin Weiss and his team predict that investing in AI healthcare companies is bigger, more sustainable and … safer.
